Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Grant | Utility: Pyridyl substituted indole compounds Filling date: 6 Sep 2025 Issue date: 26 May 2020 |
Application | Utility: ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 21 May 2020 |
Grant | Utility: Tricyclic rho kinase inhibitors Filling date: 6 Sep 2025 Issue date: 19 May 2020 |
Grant | Utility: Antibodies comprising modified heavy constant regions Filling date: 6 Sep 2025 Issue date: 19 May 2020 |
Application | Utility: TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITH Filling date: 6 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK Filling date: 6 Sep 2025 Issue date: 30 Apr 2020 |
Application | Utility: STABLE FORMULATIONS OF FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN Filling date: 6 Sep 2025 Issue date: 30 Apr 2020 |
Grant | Utility: Tricyclic sulfone compound as a ROR gamma modulator Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Immunomodulators Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Substituted tricyclic heterocyclic compounds Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 28 Apr 2020 |
Application | Utility: FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: SUBSTITUTED QUINOLINYLCYCLOHEXYLPROPANAMIDE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS Filling date: 6 Sep 2025 Issue date: 16 Apr 2020 |
Grant | Utility: Additive systems for use in protein PEGylation Filling date: 6 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Hepatitis C virus inhibitors Filling date: 6 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Heteroaryl substituted aminopyridine compounds Filling date: 6 Sep 2025 Issue date: 14 Apr 2020 |
Application | Utility: SUBSTITUTED NITROGEN CONTAINING COMPOUNDS Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: METHODS OF TREATING A TUMOR USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: PROCESS FOR THE PREPARATION OF 6-(CYCLOPROPANEAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHE- NYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: DESIGN OF THERAPEUTIC IMMUNOGLOBULIN G4 FOR IMPROVED BIOANALYTICAL AND BIOPROCESSING PROPERTIES Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: PROCESS FOR PREPARING TETRAHYDROCARBAZOLE CARBOXAMIDE COMPOUND Filling date: 6 Sep 2025 Issue date: 9 Apr 2020 |
Grant | Utility: Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN.alpha. responses Filling date: 6 Sep 2025 Issue date: 7 Apr 2020 |
Grant | Utility: Spiroheptane salicylamides and related compounds as inhibitors of rock Filling date: 6 Sep 2025 Issue date: 7 Apr 2020 |
Grant | Utility: Indole carboxamide compounds Filling date: 6 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Cancer immunotherapy by disrupting PD-1/PD-L1 signaling Filling date: 6 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Glucokinase activators and methods of using same Filling date: 6 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Fibronectin binding domains with reduced immunogenicity Filling date: 6 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Therapeutic TREM-1 peptides Filling date: 6 Sep 2025 Issue date: 31 Mar 2020 |
Application | Utility: 4-AZAINDOLE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: TETRAZOLONE-SUBSTITUTED DIHYDROPYRIDINONE MGAT2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING HETEROATOM-LINKED AROMATIC MOIETIES, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR Filling date: 6 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE Filling date: 6 Sep 2025 Issue date: 26 Mar 2020 |
Grant | Utility: 2-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors Filling date: 6 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: BSL2v2c2-Ig polypeptides Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: 1,3-dihydroxy-phenyl derivatives useful as immunomodulators Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Compositions for cell culture and methods of using the same Filling date: 6 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: B7-RELATED NUCLEIC ACIDS AND POLYPEPTIDES USEFUL FOR IMMUNOMODULATION Filling date: 6 Sep 2025 Issue date: 12 Mar 2020 |
Grant | Utility: Cancer immunotherapy by disrupting PD-1/PD-L1 signaling Filling date: 6 Sep 2025 Issue date: 10 Mar 2020 |
Showing 550 to 600 of 772 patents.